Revised Immigration Order Still Affects Scientists

Despite several changes in the Trump administration’s new immigration ban, scientists continue to voice concerns about the executive order.

Written byJoshua A. Krisch
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

President Donald Trump at a rally in Phoenix, Arizona, 2016WIKIMEDIA, GAGE SKIDMOREPresident Donald Trump’s new executive order on immigration was announced on Monday (March 6). The rules place a 90-day ban on immigration from Iran, Libya, Somalia, Sudan, Syria, and Yemen, exempting permanent US residents and all those who hold valid visas. “This executive order responsibly provides a needed pause so we can carefully review how we scrutinize people coming here from these countries of concern,” said Attorney General Jeff Sessions, according to the Washington Post.

Several of the most controversial parts of the original executive order, issued in January and met with widespread protests, have been struck from the current version. The original order would have banned residents with green cards from entering the US when traveling from seven countries, for instance. But experts within the scientific community remain concerned about its implications.

Researchers who have not yet renewed their visas or are working under single-entry visas could theoretically be barred from re-entry if they leave the country, Brendan Delaney, an immigration lawyer at Leavy, Frank & Delaney in Bethesda, Maryland, told Nature. Whether that would happen is unclear, especially since the new executive order allows waivers on a case-by-case basis. But that is little comfort to scientists living in ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies